本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Amneal Pharmaceuticals, Inc.

10.40
+0.02000.19%
盘后10.400.00000.00%18:59 EDT
成交量:121.31万
成交额:1,260.06万
市值:32.66亿
市盈率:958.61
高:10.46
开:10.33
低:10.26
收:10.38
52周最高:10.46
52周最低:6.69
股本:3.14亿
流通股本:1.69亿
量比:0.68
换手率:0.72%
股息:- -
股息率:- -
每股收益(TTM):0.0108
每股收益(LYR):-0.3783
净资产收益率:-881.26%
总资产收益率:6.85%
市净率:-29.13
市盈率(LYR):-27.49

数据加载中...

2025/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/08

重要事件披露

Form 8-K - Current report
2025/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/02

重要事件披露

Form 8-K - Current report
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/07

重要事件披露

Form 8-K - Current report
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/28

重要事件披露

Form 8-K - Current report
2025/01/15

重要事件披露

Form 8-K - Current report
2025/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

重要事件披露

Form 8-K/A - Current report: [Amend]